AbbVie Inc annual net income for fiscal 2025 was $4.2 billion, a decrease of 1.2% from $4.3 billion in fiscal 2024. Trailing-twelve-month net income is $3.6 billion. All figures are reported results from public filings — no estimates or projections.
| Net Income (annual) | TTM | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $3.6B | $4.2B | $4.3B | $4.9B | $11.8B | $11.5B | $4.6B | $7.9B | $5.7B | $5.3B | $6.0B | $5.1B | $1.8B | $4.1B | $5.3B | $3.4B | $4.2B | $4.6B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Net Income (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $699M | $1.8B | $186M | $938M | $1.3B | ($22M) | $1.6B | $1.4B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More ABBV metrics: Revenue · Gross Profit · Operating Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All ABBV financial statements → Interactive ABBV charts →
About TickerBase · Data methodology & sources